Following is a Pfizer generated document we received on Friday, January 13, 2012:
Pfizer Inc. is recalling multiple lots of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03mgTablets manufactured and packaged by Pfizer, and distributed and commercialized by Akrimax Pharmaceuticals, LLC (see below for lot numbers and expiration dates). Please note that these products are labeled with Akrimax labeling. Pfizer Inc. voluntarily initiated this recall when it was determined that some blister packs may contain an inexact count of placebo or active ingredient tablets. Please note that use of this product is not likely to cause adverse health consequences.
FEDERAL REGULATIONS REQUIRE THAT YOU RESPOND TO THIS RECALL, EVEN IF YOU DO NOT HAVE THE RECALLED PRODUCT. TO RESPOND, PLEASE CONTACT STERICYCLE INC. AT 1(800)-805-3093 WITHIN FIVE (5) BUSINESS DAYS.
The recall of LO/OVRAL - 28 Tablets and Norgestrel 0.3mg/Ethinyl Estradiol 0.03 mg Tablets is being conducted to the retail level.
Records indicate that you may have received shipment of affected lots between January 2011 and December 2011. Please check your stock immediately against the table below. If you have any of the affected products in your inventory, please stop distribution and promptly return to Stericycle Inc. 2670 Executive Drive, Suite A Indianapolis, IN 46241: Attn: Event 2568. Please contact Stericycle Inc. at (800) 805-3093 if you require the pre-paid UPS labels. If you have any medical inquiries regarding these products, please contact Akrimax Medical Information at 1(877)509-3935 (8 AM to 7 PM Mon-Fri CST).
If you have further distributed the lots to the retail level, please conduct a sub-recall and communicate this recall information to those accounts immediately. Please request that they immediately cease distribution of the affected lots and promptly return the product directly to the above address. If they have inventory of the affected product, they can contact Stericycle Inc. at (800) 805-3093 to obtain pre-paid shipping labels for product return. Further authorization is not required for product return. Reimbursement for the returned product will be made by credit memorandum. If you have any questions regarding the reimbursement, please contact your Akrimax Customer Service Representative at 1(877) 509-3935 (8 AM to 7 PM Mon-Fri CST).
This recall is being conducted with the knowledge of the U.S. Food and Drug Administration. We appreciate your immediate attention and cooperation to this matter.
LO/OVRAL® - 28
LOT# Expiration Date
E15678 8/31/2013
E15679 8/31/2013
E15686 8/31/2013
E15687 1/31/2014
E15690 1/31/2014
E15698 1/31/2014
E15700 2/28/2014
E80434 7/31/2013
E80438 8/31/2013
F36908 2/28/2014
F36909 2/28/2014
F43915 3/31/2014
F43926 3/31/2014
F43927 3/31/2014
NORGESTREL 0.3MG/ETHINYL ESTRADIOL 0.03 MG
LOT# Expiration Date
E15677 8/31/2013
E15704 1/31/2014
E15706 1/31/2014
E80440 8/31/2013
F16388 1/31/2014
F16390 2/28/2014
F22132 2/28/2014
F31330 2/28/2014
F36911 3/31/2014
F36913 3/31/2014
F43924 3/31/2014
F43925 3/31/2014
F43934 3/31/2014
F53238 3/31/2014
Save 10% off your first purchase of 12 Bottles of Daily-Vites.
Folic Acid is a B vitamin that helps a baby's neural tube grow healthy during pregnancy. The neural tube will become a baby's brain and spinal cord. But if the neural tube doesn't close the way it should, it can cause a very serious birth defect called a neural tube defect (NTD).
Please contact your R&S Sales Representative for pricing.
Pennsylvania (800) 262-7770
Ohio (866) 994-7472
Kentucky (866) 228-9758
Call 888.377.2203 or visit www.gyndisposables.com
Public Release Date: 26-March-2009
Summary of "Family Planning and Health Care Reform: The Benefits and Challenges of Prioritizing Prevention," Gold, Guttmacher Policy Review, Winter 2009.
President Obama's administration and Congress have indicated an interest in pursuing health care reform that prioritizes prevention, and "family planning exemplifies both the benefits of prevention and the issues inherent in trying to remake the current health financing system to work for prevention," Rachel Benson Gold of the Guttmacher Institute writes in a Guttmacher Policy Review article.
Public Release Date: 24-November-2008
The Washington Post Magazine on Sunday examined challenges medical students face when considering whether to become abortion providers. According to the Post Magazine, the number of abortion providers in the U.S. is declining, and "unless a new generation [takes] their place, the right to abortion might be rendered meaningless." The Post Magazine profiled Lesley Wojcik -- a medical student at the University of Maryland School of Medicine -- who was considering becoming an abortion provider but ultimately decided to forgo her plans.
Public Release Date: 12-October-2008
An extensive study of how the nursing profession has been portrayed in films over the last century has shown that unflattering stereotypes are becoming less common and nurses are now being portrayed in a more positive light.
Continue reading "Project Highlights Changing Face of Nurses in Films Over the Last 100 Years "
Public Release Date: 14-May-2008
Sexually transmitted infections (STIs) have been in the news recently as new epidemiologic trends emerge:
CFHC has collaborated with staff at the California STD Branch at the California Department of Public Health to highlight important strategies for preventing and treating STIs as recommended by the CDC in their STD Treatment Guidelines.
Recommendations for HPV vaccination and changes in the management of abnormal Pap tests are also noted. Providers are invited to download the 2-page California STD Treatment Summary Table (PDF) and refer to the California STD Clinical Guidelines for further information on the latest recommendations for screening, testing, treatment, and partner management for STIs in California.
Written by: Ina Park M.D., M.S., Clinical STD Fellow, California Department of Public Health-STD Control Branch
Posted thanks to News & Views, a quarterly publication of the California Family Health Council, Inc.
Public Release Date: 24-July-2007
CHICAGO -- Medicare patients who couldn't read a physician's instructions, or who didn't understand what they read had a higher mortality rate than patients with adequate reading skills.
After adjusting for demographics, socioeconomic status, disability, and chronic conditions, patients with inadequate health literacy were 52% more likely to die during an average of 67.8 months of follow-up (P<0.001), according to a study reported in the July 23 issue of Archives of Internal Medicine.
Continue reading "Literacy Linked to Survival in Medicare Patients"
Public Release Date: 10-May-2007
WASHINGTON, May 10 -- An employee health program incorporating a fitness center, health education, and incentives improved workers' cardiovascular health and workplace safety, investigators reported here.
Employees who availed themselves of those services improved blood pressure control by 9% and diabetes control by 15%, found Sharon A. Clark, D.H.Sc., of JEA, the municipal utility company in Jacksonville, Fla., and colleagues.
Continue reading "AHA Forum: Healthy Workplace, Healthy Workers"
Public Release Date: 9-May-2007
SAN DIEGO -- Those who battled the FDA for non-prescription status of Plan B (levonorgestrel) apparently won only half the struggle. Prescription or not, Plan B can be hard to get.
A survey of Plan B availability in three major cities found that state laws can override the ease of access to the emergency contraception agent, whether by prescription or "under-the-counter" sales.
Continue reading "ACOG: Plan B Availability Varies from State to State"